Galenica Sante Ag Stock Gross Profit

GALE Stock  CHF 70.55  0.55  0.79%   
Galenica Sante AG fundamentals help investors to digest information that contributes to Galenica Sante's financial success or failures. It also enables traders to predict the movement of Galenica Stock. The fundamental analysis module provides a way to measure Galenica Sante's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Galenica Sante stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Galenica Sante AG Company Gross Profit Analysis

Galenica Sante's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Galenica Sante Gross Profit

    
  427.92 M  
Most of Galenica Sante's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Galenica Sante AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

According to the company disclosure, Galenica Sante AG reported 427.92 M of gross profit. This is 80.92% lower than that of the Healthcare sector and 54.99% lower than that of the Biotechnology industry. The gross profit for all Switzerland stocks is 98.44% higher than that of the company.

Galenica Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Galenica Sante's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Galenica Sante could also be used in its relative valuation, which is a method of valuing Galenica Sante by comparing valuation metrics of similar companies.
Galenica Sante is currently under evaluation in gross profit category among related companies.

Galenica Fundamentals

About Galenica Sante Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Galenica Sante AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galenica Sante using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galenica Sante AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Galenica Sante in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Galenica Sante's short interest history, or implied volatility extrapolated from Galenica Sante options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galenica Sante AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Galenica Stock analysis

When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Please note, there is a significant difference between Galenica Sante's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galenica Sante is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galenica Sante's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.